MedMira gibt Fortschrittsbericht zu seinem REVEALCOVID-19™-Gesamtantikörpertest einschließlich CE-Kennzeichnung bekannt
22 mai 2020 11h01 HE
|
MedMira Inc.
Halifax, Nova Scotia (Kanada), May 22, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) hat heute bekanntgegeben, dass das Unternehmen den Registrierungsprozess abgeschlossen hat und sein...
MedMira fait un point sur les progrès réalisés concernant REVEALCOVID-19™, son test global pour la détection d'anticorps, comprenant l'apposition du marquage CE
22 mai 2020 11h01 HE
|
MedMira Inc.
HALIFAX, Nouvelle-Écosse, 22 mai 2020 (GLOBE NEWSWIRE) -- Aujourd'hui, MedMira Inc. (MedMira) (TSXV : MIR) a annoncé avoir terminé le processus d'enregistrement et d'apposition du marquage CE...
MedMira Announces Progress Update of its REVEALCOVID-19™ Total Antibody Test Including CE Mark
21 mai 2020 12h26 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, May 21, 2020 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announced that it has completed the registration process and affixed the CE mark (Conformité...
MedMira Announces Notification Submission to US FDA Emergency Use Authorization
23 avr. 2020 07h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, April 23, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), announced today that it had submitted the notification for the Emergency Use Authorization application...
MedMira gibt ein Update zur Entwicklung eines Point-of-Care-Antikörpertests bekannt
20 avr. 2020 10h32 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, April 20, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), hat heute bekanntgegeben, dass es die Entwicklung einer serologischen Point-of-Care-(POC)-Testlösung mit...
MedMira annonce une mise à jour concernant le développement de son test de détection d'anticorps sur le lieu de soins
20 avr. 2020 10h32 HE
|
MedMira Inc.
HALIFAX, Nouvelle-Écosse, 20 avr. 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV : MIR) a annoncé aujourd'hui avoir achevé le développement de la solution de test sérologique sur le lieu...
MedMira Announces Update on Development of Point-of-Care Antibody Test
17 avr. 2020 11h01 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, April 17, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has completed the development of the serological Point-of-Care (POC) testing...
MedMira Announces Update on Development of Point-of-Care Antibody Test
15 avr. 2020 20h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, April 15, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has completed the development of the serological Point-of-Care (POC) testing...
MedMira Reports Second Quarter Results FY2020
31 mars 2020 18h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, March 31, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended January 31, 2020. Profit and Loss...
MedMira Reports First Quarter Results FY2020
30 déc. 2019 19h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, Dec. 30, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2019. Profit and Loss...